Medication Guide App

Label Changes for:

Omontys (Peginesatide) Injection

December 2012

Changes have been made to the CONTRAINDICATIONS, WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – December 2012

 

CONTRAINDICATIONS

  • Serious allergic reactions to OMONTYS which may include anaphylaxis
 
Hide
(web4)